Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
- 1 August 1976
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 116 (2) , 180-182
- https://doi.org/10.1016/s0022-5347(17)58737-6
Abstract
Patients with recurrent superficial bladder tumors were treated by vesical and intradermal administration of BCG. The pattern of recurrence in 9 patients was altered favorably. Although the findings are still preliminary they appear to hold promise of a new therapeutic approach to the treatment of a group of neoplasms for which effective therapy is still lacking.This publication has 15 references indexed in Scilit:
- Treatment of Multiple Superficial Papillary Tumors of the Bladder by Intracavitary Yttrium-90Journal of Urology, 1975
- RESULTS OF ADMINISTERING B.C.G. TO PATIENTS WITH MELANOMAThe Lancet, 1974
- Immunotherapy of guinea pig cancer with bcgCancer, 1974
- INCREASED CYTOLYTIC ACTIVITY OF A SUBCELLULAR FRACTION FROM MOUSE LIVER AFTER B.C.G. INFECTIONThe Lancet, 1973
- Correlation Among Host Immunocompetence and Tumor Stage, Tumor Grade and Vascular Permeation in Transitional CarcinomaJournal of Urology, 1973
- BCG stimulation of immune responsiveness in patients with malignant melanoma.Preliminary reportCancer, 1973
- The Management of Superficial Bladder Tumours with Intravesical Epody1British Journal of Urology, 1973
- SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTESThe Journal of Experimental Medicine, 1972
- Immune response to urinary bladder tumours in manInternational Journal of Cancer, 1970
- Thiotepa Bladder Instillations: Therapy and Prophylaxis for Superficial Bladder TumorsJournal of Urology, 1969